Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Gross Margin Growth (3y) (2013 - 2026)

Analysis

Repligen (RGEN) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 24.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 151.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 1,613.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 419.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 39.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -212.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -10.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 373.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 664.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -32.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 373.00
Mar 31, 2026 523.00
Dec 31, 2025 103.00
Sep 30, 2025 -367.00
Jun 30, 2025 -746.00
Mar 31, 2025 -609.00
Dec 31, 2024 -3,283.00
Sep 30, 2024 -760.00
Jun 30, 2024 -1,063.00
Mar 31, 2024 -804.00
Dec 31, 2023 -857.00
Sep 30, 2023 -3,198.00
Jun 30, 2023 -768.00
Mar 31, 2023 -746.00
Dec 31, 2022 -521.00
Sep 30, 2022 215.00
Jun 30, 2022 189.00
Mar 31, 2022 437.00
Dec 31, 2021 143.00
Sep 30, 2021 243.00